News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Iris Pharma and Clirophtha Merger Creates Unique Ophthalmology CRO


1/4/2008 9:10:36 AM

Nice (France), 17 December 2007 – Iris Pharma of France, a specialist contract research organisation (CRO) for pre-clinical research in ophthalmology, has announced the completion of its merger with Clirophtha, a unique CRO in Europe and North America that is completely dedicated to ophthalmology clinical trials. The new entity will be known as Iris Pharma.

“The merger of Iris Pharma and Clirophtha is an opportunity to increase pharmaceutical and biotech companies’ ability to develop the potential of their ophthalmologic drugs,” says Dr Pierre-Paul Elena, Founder and CEO of Iris Pharma.




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES